DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $54,081,000 | -26.9% | 2,682,596 | +35.3% | 0.01% | -28.6% |
| Q2 2021 | $74,003,000 | +70.9% | 1,982,925 | +17.1% | 0.01% | +75.0% |
| Q1 2021 | $43,295,000 | -5.2% | 1,693,182 | -18.3% | 0.00% | -20.0% |
| Q4 2020 | $45,651,000 | +21.2% | 2,072,217 | -1.0% | 0.01% | +25.0% |
| Q3 2020 | $37,665,000 | -38.1% | 2,093,678 | -12.6% | 0.00% | -50.0% |
| Q2 2020 | $60,820,000 | +26.0% | 2,394,482 | -8.9% | 0.01% | 0.0% |
| Q1 2020 | $48,262,000 | -33.2% | 2,627,226 | -19.9% | 0.01% | -11.1% |
| Q4 2019 | $72,281,000 | +294.2% | 3,281,024 | +156.9% | 0.01% | +200.0% |
| Q3 2019 | $18,336,000 | +1.0% | 1,276,912 | +10.7% | 0.00% | 0.0% |
| Q2 2019 | $18,160,000 | +66.2% | 1,152,999 | +54.5% | 0.00% | +50.0% |
| Q1 2019 | $10,929,000 | +207.3% | 746,039 | +124.3% | 0.00% | +100.0% |
| Q4 2018 | $3,556,000 | +345.1% | 332,615 | +297.9% | 0.00% | – |
| Q1 2018 | $799,000 | -83.6% | 83,594 | -51.6% | 0.00% | -100.0% |
| Q1 2014 | $4,882,000 | – | 172,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|